Latest Insider Transactions at Immix Biopharma, Inc. (IMMX)
This section provides a real-time view of insider transactions for Immix Biopharma, Inc. (IMMX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Immix Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Immix Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2024
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
8,100
+0.95%
|
$16,200
$2.25 P/Share
|
|
Aug 21
2024
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
15,000
+1.76%
|
$30,000
$2.23 P/Share
|
|
Aug 16
2024
|
Carey Ng Director |
BUY
Open market or private purchase
|
Direct |
10,000
+33.33%
|
$10,000
$1.86 P/Share
|
|
Jul 24
2024
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
6,000
+0.72%
|
$12,000
$2.15 P/Share
|
|
Jul 18
2024
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
3,200
+0.39%
|
$6,400
$2.07 P/Share
|
|
Jun 07
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
2,600
+0.23%
|
$5,200
$2.13 P/Share
|
|
Jun 07
2024
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.87%
|
$5,000
$2.12 P/Share
|
|
Jun 04
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
3,300
+0.29%
|
$3,300
$1.81 P/Share
|
|
Jun 04
2024
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
3,300
+1.15%
|
$3,300
$1.81 P/Share
|
|
May 20
2024
|
Gabriel S Morris CFO |
BUY
Grant, award, or other acquisition
|
Indirect |
48,282
+29.09%
|
-
|
|
May 20
2024
|
Gabriel S Morris CFO |
BUY
Grant, award, or other acquisition
|
Direct |
194,218
+40.95%
|
-
|
|
May 20
2024
|
Magda Marquet Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,155
+31.46%
|
-
|
|
May 20
2024
|
Melissa Jane Buchan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+4.78%
|
-
|
|
May 20
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
218,359
+16.19%
|
-
|
|
May 20
2024
|
Helen C. Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,241
+29.82%
|
-
|
|
May 15
2024
|
Magda Marquet Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,002
+50.0%
|
-
|
|
May 15
2024
|
Melissa Jane Buchan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,332
+5.88%
|
-
|
|
May 15
2024
|
Helen C. Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
87,740
+46.55%
|
-
|
|
May 14
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
4,300
+0.47%
|
$8,600
$2.25 P/Share
|
|
May 14
2024
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
4,500
+4.98%
|
$9,000
$2.23 P/Share
|
|
Dec 11
2023
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
31,000
+3.67%
|
$124,000
$4.67 P/Share
|
|
Dec 08
2023
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
25,000
+3.1%
|
$100,000
$4.88 P/Share
|
|
Sep 15
2023
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
7,000
+0.92%
|
$14,000
$2.49 P/Share
|
|
Sep 14
2023
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.32%
|
$20,000
$2.58 P/Share
|
|
Sep 14
2023
|
Carey Ng Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.58 P/Share
|
|
Sep 12
2023
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
30,000
+3.9%
|
$60,000
$2.83 P/Share
|
|
Sep 12
2023
|
Helen C. Adams Director |
BUY
Open market or private purchase
|
Direct |
13,000
+50.0%
|
$26,000
$2.96 P/Share
|
|
Sep 11
2023
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
25,000
+3.4%
|
$50,000
$2.89 P/Share
|
|
Sep 08
2023
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Direct |
10,000
+1.44%
|
$20,000
$2.53 P/Share
|
|
Sep 07
2023
|
Melissa Jane Buchan Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$40,000
$2.46 P/Share
|
|
Sep 06
2023
|
Magda Marquet Director |
BUY
Open market or private purchase
|
Indirect |
9,000
+31.03%
|
$18,000
$2.47 P/Share
|
|
Sep 05
2023
|
Magda Marquet Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+47.62%
|
$20,000
$2.47 P/Share
|
|
Aug 31
2023
|
Magda Marquet Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+50.0%
|
$2,000
$2.01 P/Share
|
|
Nov 14
2022
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
5,200
+6.01%
|
$0
$0.94 P/Share
|
|
Nov 14
2022
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
5,200
+0.19%
|
$0
$0.99 P/Share
|
|
Jul 14
2022
|
Sean Senn > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200
-0.02%
|
$400
$2.75 P/Share
|
|
Dec 20
2021
|
Carey Ng Director |
BUY
Open market or private purchase
|
Indirect |
25,000
+2.38%
|
$125,000
$5.0 P/Share
|
|
Dec 20
2021
|
Carey Ng Director |
BUY
Conversion of derivative security
|
Indirect |
1,000,221
+50.0%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+2.56%
|
$10,000
$5.0 P/Share
|
|
Dec 20
2021
|
Gabriel S Morris CFO |
BUY
Conversion of derivative security
|
Indirect |
246,703
+41.65%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Gabriel S Morris CFO |
BUY
Conversion of derivative security
|
Direct |
74,116
+50.0%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Vladimir P Torchilin Scientific Co-Founder |
BUY
Open market or private purchase
|
Direct |
3,000
+0.33%
|
$15,000
$5.0 P/Share
|
|
Dec 20
2021
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+50.0%
|
$250,000
$5.0 P/Share
|
|
Dec 20
2021
|
Jason Hsu Director |
BUY
Conversion of derivative security
|
Indirect |
3,915,913
+50.0%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
2,500
+0.28%
|
$12,500
$5.0 P/Share
|
|
Dec 17
2021
|
Vladimir P Torchilin Scientific Co-Founder |
BUY
Open market or private purchase
|
Direct |
2,200
+0.24%
|
$8,800
$4.47 P/Share
|